Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 10, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma to Present at the 2015 Jefferies Immuno-Oncology Summit in Boston

SANTA MONICA, Calif., April 10, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
April 06, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Announces Publication in Science of Cancer Immunotherapy Articles Authored by Lead Collaborators at the National Cancer Institute and the Netherlands Cancer Institute

SANTA MONICA, Calif., April 6, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
March 26, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Reports Full-Year and Fourth Quarter 2014 Financial Results

SANTA MONICA, Calif., March 26, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
March 25, 2015 21:00 ET | Source: Kite Pharma, Inc.

Kite Pharma to Report Fourth Quarter and Full Year 2014 Financial Results on March 26th, 2015

SANTA MONICA, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
March 17, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Strengthens Its T Cell Receptor (TCR) Cancer Gene Therapy Platform Through Acquisition of T-Cell Factory B.V. (TCF(TM))

- Kite Pharma EU Established as European Headquarters in Amsterdam, Appointing Ton N. M. Schumacher Ph.D. as its Chief Scientific Officer - - Kite to Expand Product Pipeline in TCRs for the...
March 06, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma to Present at the 2015 Barclays Global Healthcare Conference

SANTA MONICA, Calif., March 6, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
March 02, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Expands Its Research and Development Collaboration With the National Cancer Institute to Develop a Next Generation of Cancer Immunotherapy Products for Solid Tumors

-Focus on T Cell Response to Tumor-Specific Mutations- -Expansion of TCR and CAR Product Pipeline- SANTA MONICA, Calif., Feb. 27, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), a...
February 23, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma to Present at the Cowen and Company 35th Annual Health Care Conference

SANTA MONICA, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
February 19, 2015 08:00 ET | Source: Kite Pharma, Inc.

Kite Pharma Establishes Manufacturing Capabilities to Support Development and Commercialization of CAR and TCR Cancer Immunotherapy Products

SANTA MONICA, Calif., Feb. 19, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...
February 02, 2015 16:30 ET | Source: Kite Pharma, Inc.

Kite Pharma to Present at the 17th Annual BIO CEO & Investor Conference

SANTA MONICA, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy...